In this high-impact, field-based role, you will drive the adoption and growth of Signatera, Natera''s personalized molecular residual disease (MRD) ctDNA assay, helping clinicians monitor cancer and inform treatment decisions throughout the patient journey. The Natera team consists of highly dedicated statisticians, geneticists, doctors, laboratory scientists, business professionals, software engineers and many other professionals from world-class institutions, who care deeply for our work and each other.